ArticleCellular and molecular neurobiology2025
Identification of Key Ferroptosis-Related Genes as Potential Diagnostic Biomarkers for Ischemic Stroke: Evidences from Integrated Bioinformatics Analysis and Experiments.
Article in Cellular and molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ferroptosis, an iron-dependent form of regulated cell death, has been linked to the occurrence and progression of ischemic stroke (IS). This study aims to uncover the key ferroptosis-related genes in IS and their correlations with immunoinflammatory responses. Key differentially expressed ferroptosis-related genes were screened by integrating differential analysis, weighted gene co-expression network analysis (WGCNA), and protein-protein interaction analysis. Machine learning algorithms, LASSO regression, Random Forest, RGF, and LightGBM were employed to identify potential diagnostic biomarkers, and diagnostic model was then established. Oxygen-glucose deprivation/reoxygenation (OGD/R)-stimulated HT-22 cells were established to validate the expression of biomarkers by RT-qPCR and western blot. Fifteen key ferroptosis-related genes were identified by integrated analyses, and ATM, DUSP1, SRC, and STAT3 were further screened as biomarkers by four algorithms. The diagnostic model established based on these four biomarkers exhibited well predictive power for IS, with AUC over 0.8 in both training and validation sets. Expression of DUSP and STATS positively correlated with neuroinflammation pathway, and positively correlated with abundance of neutrophils and macrophages. SRC positively correlated with abundance of monocytes, whereas ATM positively correlated with CD8 T cells and resting memory CD4 T cells. Both mRNA and protein levels of DUSP1, SRC, and STATS3 were significantly enhanced, while the level of ATM was reduced in OGD/R-stimulated HT-22 cells than control cells. In conclusion, dysregulation of key ferroptosis-related genes, ATM, DUSP1, SRC, and STAT3 might be implicated in the progression of IS, which could be biomarkers or targets for the diagnosis and therapy of IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.